ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

PET Three Months After Therapy Provides Early Warning Of Need For Intervention

November 30, 2007

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

Court Filing By Fisher; Board, Attacks Interim NSABP Leadership

August 12, 1994

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady wins RSNA Medal

January 12, 1990

Scientists, Advocates Voice Objections To von Eschenbach’s Conflicts, 2015.

November 22, 2006

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013